No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
MRK250117C87500
- 11.95
- +0.40+3.46%
15min DelayClose Jan 14 16:00 ET
12.25High11.95Low
12.25Open11.55Pre Close3 Volume105 Open Interest87.50Strike Price3.65KTurnover65.79%IV-0.20%PremiumJan 17, 2025Expiry Date12.15Intrinsic Value100Multiplier3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9891Delta0.0050Gamma8.17Leverage Ratio-0.0289Theta0.0066Rho8.08Eff Leverage0.0025Vega
Intraday
- 5D
- Daily
News
Jim Cramer Says He Supports Healthcare Stocks for Their Long-term Value
Boeing, NVIDIA Corp. Share Losses Lead Dow's 113-Point Drop
BMO Capital Maintains Merck & Co(MRK.US) With Hold Rating, Maintains Target Price $105
Jefferies Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $150
Merck & Co.'s Accelerated Keytruda Launch and Strategic Updates Bolster Long-term Growth Prospects
Merck Eyeing 2025 Launch for Easier-to-use Keytruda